Navigation Links
Kendle Invites You to Attend its Second Quarter 2008 Earnings Conference Call and Webcast
Date:7/16/2008


CINCINNATI, July 16 /PRNewswire-FirstCall/ --

CALL DATE: Wednesday, Aug. 6, 2008

TIME: 9:30 a.m. Eastern Time

HOST: Dr. Candace Kendle, Chairman and CEO

Kendle (Nasdaq: KNDL) will conduct a telephone conference call and simultaneous webcast on Wednesday, Aug. 6 at 9:30 a.m. Eastern Time to discuss its financial results for the Second Quarter ended June 30, 2008. A question and answer session will follow.

Webcast Instructions

To access the live webcast, visit the company Web site at http://www.kendle.com or link to the Webcast directly at http://www.videonewswire.com/event.asp?id=50021 . Instructions for accessing the webcast are provided at both sites. The webcast will be archived at http://www.kendle.com (click on "Investors" and then "Events & Presentations") shortly after the call for on-demand replay through 5 p.m. Eastern Time on Sept. 5, 2008. Please note that webcast participants will not be able to ask questions.

System requirements for the webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx .

Conference Call Instructions

To register (RSVP) for the telephone conference call, U.S. and Canadian participants should dial (800) 223-7104. Participants outside North America should dial (706) 645-6519.

To participate in the telephone conference
'/>"/>

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress
2. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
3. Kendle Appoints Patricia Williams Vice President, Commercial Operations
4. Kendle Invites You to Attend its First Quarter 2008 Earnings Conference Call and Webcast
5. Kendle to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
6. Kendle Leaders Adopt 10b5-1 Trading Plans
7. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
8. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
9. Kendle to Present at the Wachovia 2008 Healthcare Conference
10. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
11. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...E, Gabon, December 2 , - ...blem and Heritage" , Coinciding with the ...the,Gabonese Republic is hosting an international ...afeguarding biological resources in Africa. The,co...leaders, ministers,scientific experts, private co...
(Date:12/2/2009)...E, Mass., Dec. 2 TechConnect World...logy development and product integration in cleant...ember 11th deadline for technology abstracts and b... TechConnect World, in association with the Nano S...ean Technology and Sustainable Industries Organiza...
(Date:12/2/2009)...E, Dec. 2 S*BIO Pte Ltd today anno...hibitor, SB1518, at The American Society of Hemato...eans. ,, Data will be presented on the clinical... SB1518 detailing its safety, tolerability and pha...se levels ranging from 100 to 600 mg. These doses ...
(Date:12/2/2009)..., China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharm...: SCR ), a leading pharmaceutical company,specia...eting of branded,generic and proprietary pharmaceu...rugs have been included in China,s National Drug R...ina,s Ministry of Human Resources and Social,Secur...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
...eneCopoeia announces the launch of a suite of miRN...lude 1) miExpress(TM) vector based precursor miRNA...equence (3, UTR) expression clones; and 3) All-in-...a lentiviral vector system, miExpress(TM) precurs...nown miRNAs for human (750), mouse (450), and rat ...
...scheduled for March 12, 2009 , , NEW YORK, March... ) today announced that it received a letter from ...at the Company had failed to regain compliance wit...es the Company to have a minimum of $2,500,000 in ...of listed securities, or $500,000 of net income fr...
...eoGenomics, Inc. (NASD OTC Bulletin Board: NGNM), ...ng laboratories, today announced its results for t... 2008. , , Fourth Quarter 2008 Highlights: ...ase of 56% year-over-year from Q4 07 , 17.... 08 , Avg. Rev/Requisition increased 13.7%...
Other Biology Technology:GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools 2Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 2Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 3Keryx Biopharmaceuticals Inc. Announces Receipt of Nasdaq Delisting Notification 4NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 2NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 3NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 4NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 5NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 6NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 7NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results 8
(Date:12/3/2009)..., Preliminary Press Conference Topics, Last Cal...ces museum, Attention PIOs: Sending Press Releas...ration deadline 10 December, News Media registra...pre-registration deadline THIS MONDAY, 7 December,...regarding visas for international reporters, pleas...
(Date:12/3/2009)...by a social snubbing? Your genetics, not your frie...wn that opium-like painkillers, called opioids, re...of emotional stress. Now, a new study reviewed by ... that small genetic differences in the gene for th...eople,s responses to social rejection. , In the...
(Date:12/3/2009)...tic snowmelt that occurred during the 2008-09 aust...itive phases for two main climate drivers, ENSO (E...misphere Annular Mode), according to Dr. Marco Ted...ciences at The City College of New York. , Pro...y at the CUNY Graduate Center, added that Antarcti...
Breaking Biology News(10 mins):AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6CCNY professor foresees rising Antarctic snowmelt 2UCF Athletes Set Example While Getting Protected Against Flu 58583 1UCF Athletes Set Example While Getting Protected Against Flu 58583 2Delayed First Visit to Dentist Can Affect Childrens Lifelong Oral Health 58581 1Delayed First Visit to Dentist Can Affect Childrens Lifelong Oral Health 58581 2Private Care Association of Floridas Elects Jim Mark as Vice President 58579 1Private Care Association of Floridas Elects Jim Mark as Vice President 58579 2
...n University] Leading academics and practitioners... latest advances in bioengineering research and na... from ink jets and a new, injectable method for re... Brown University April 4-6, 2008. , It is the fi...t Bioengineering Conference, which will take place...
...rean delivery for their first child go on to have ...aditional way. This is shown in a study from the N...versity of Bergen. , Researchers at the NIPHs Med...ave collected data on all first-time births from 1...vers nearly 600 000 births, so the results are sta...
...er to saving the Earth from global warming lie in ...le University aims to design soils that can remove...effectively. This has never previously been attemp...unded by the Engineering and Physical Sciences Res...iative exploits the fact that plants, crops and tr...
Other Biology News:Brown hosts regional bioengineering conference 2Fewer babies born after Caesarean delivery 2Specially-designed soils could help combat climate change 2
Cell Proliferation Kit from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Human Dysadherin 2 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Human Bcl-2, phospho (Thr74) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Trx-2 Monoclonal Antibody, Unconjugated, Clone 71G4 from Santa Cruz Biotechnology, Inc.
Biology Products: